Add like
Add dislike
Add to saved papers

Unraveling depression: principles and practices of clinical hypnosis.

People struggling with depression are burdened by losses they can't and won't accept. They find themselves at odds not only with their circumstances, but also with symptomatic expressions of their exhausting efforts to shelter from, gird against, and contend with their pain and desolation. Their embattled sense of self gets no respite: Everything, including the depression itself, feels threatening, a violation, other . This article investigates why, and demonstrates how, hypnosis is particularly well suited for treating such self-referential, adversarial entanglements. Fundamentally associational in both structure and function, hypnosis resonates with other long-established, connection-based traditions for altering suffering. In keeping with Taoist, Sufi, and Buddhist ideas and practices, hypnosis introduces a quality of acceptance into the relationship between self and other, between self and pain. Clinical hypnosis establishes and maintains a context of interpersonal and intrapersonal security, a protective space and a relationship in which avolitional experience is not felt to be out-of-control or uncontrollable, but rather not-in-need-of-being-controlled. It thus becomes safe for clients to become curious about, approach, and engage with what in other settings would have the potential of producing a fearful, even panicky, reaction. By altering the boundary between clients and their suffering, clinicians facilitate an effortless rapprochement, making possible the shifting, repurposing, and unraveling of symptoms.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app